Otsuka’s kidney therapy gets accelerated FDA approval
Voyxact gets accelerated approval, offering investors a new entrant in the high-value kidney disease market. The Food and Drug Administration...
Voyxact gets accelerated approval, offering investors a new entrant in the high-value kidney disease market. The Food and Drug Administration...
Mental health conditions are common among veterans and may play a larger role than previously recognized in raising liver cancer...
Chronic kidney disease is increasingly affecting younger generations in Vietnam, reflecting a broader trend of early-onset chronic illnesses that threaten...
Researchers have found a previously unknown mutation in the factor VIII (FVIII) gene that accelerates blood clotting. This discovery could...
Demand for Autosomal Dominant Polycystic Kidney Disease Treatment in USA Forecast and Outlook (2025–2035) The demand for autosomal dominant polycystic...
Local supporters, including former patient Cam Neil and family, gather to cut the ribbon for the new Sargent Family...